Anzeige
Mehr »
Donnerstag, 12.03.2026 - Börsentäglich über 12.000 News
Dieser 37-Mio.-€-Goldentwickler sitzt auf einem möglichen $2-Milliarden-Projekt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
354 Leser
Artikel bewerten:
(2)

CHCC 2026 Opens Registration, Offering a One-Stop Platform for Hospital Construction Solutions and Real-World Applications

TIANJIN, China, Jan. 28, 2026 /PRNewswire/ -- The 27th China Hospital Construction Conference & International Hospital Build and Infrastructure Exposition (CHCC 2026), a globally recognized hospital construction event, will be held from May 23 to 25, 2026, at the National Convention and Exhibition Center (Tianjin), China.

Having been held successfully for 26 consecutive editions, CHCC has evolved into a widely recognized industry platform in the hospital construction sector, bringing together academic insights and industry practice. The event offers a one-stop platform for healthcare infrastructure professionals to learn, network, and explore practical solutions.

CHCC2026 will feature an exhibition spanning over 100,000 square meters, showcasing solutions from more than 800 qualified suppliers worldwide. The event is expected to attract over 60,000 professional visitors and more than 150 delegations. In parallel, the conference program will host over 100 forums with more than 1,000 speakers, drawing an anticipated audience of over 10,000 attendees.

Designed as an immersive, use-case-driven experience, CHCC 2026 is structured around eight themed pavilions, covering areas of operational efficiency, innovation in specialized medical systems, integrated building systems, interior environments, clinical space upgrades, cleanroom engineering, hospital wards, and AI technologies. Within these halls, 40 exhibition zones will cover the end-to-end hospital construction procurement process, spanning hospital planning and design, mechanical and electrical systems, interior finishing, specialized medical engineering solutions, medical equipment, medical robots, digitally enabled hospital operations, and logistics and operations management. Together, they will present thousands of integrated, application-ready solutions shaping the future of modern healthcare infrastructure.


Why Attend CHCC 2026?

1. Access complete hospital construction solutions through a one-stop platform

2. Get insights from over 1,000 experts on trends, case studies, and emerging practices in hospital construction

3. Engage in exclusive activities, including the CHCC Awards Ceremony, pre-conference training, hospital tours, book launches, and leadership talks

"This year (2025) marks our fifth year of participating in CHCC. Every exhibition has been an unforgettable experience! CHCC is a powerful platform for global business communication and growth, offering innovative solutions and unique opportunities. If you're looking to expand your influence or explore new markets, it's definitely worth a try," said Athena, President of the China German Hortig-rohrpost Group.

Held alongside the exhibition, the conference program will provide comprehensive coverage across the hospital construction process, featuring forward-looking insights and in-depth discussions across seven core areas: healthcare infrastructure, digitally enabled hospital operations, integrated medical and senior care, medical engineering, hospital facilities and logistics management, medical robotics, and clinical discipline development.

CHCC 2026 invites healthcare infrastructure professionals worldwide to visit the exhibition and join this landmark event dedicated to the planning, construction, and operation of modern healthcare facilities.

Official website: https://www.chccchina.com/en

Get your free expo ticket: https://reg.reed-sinopharm.com/pc/#/login?id=25aa73cabd5b411c9052360160ba58e3&channelUuid=dde1a7af3a0e4db68dbd6ef51c4b6a5b

Event Organizer:

CHCC2026 is jointly organized by Zhuyitai, Reed Sinopharm Exhibitions (RSE), and Z&R Exhibitions. Notably, RSE is a joint venture between Sinopharm, China's largest healthcare group, and RX Global, a world-leading event organizer.

Photo - https://mma.prnewswire.com/media/2871388/image_5054076_20260255.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/chcc-2026-opens-registration-offering-a-one-stop-platform-for-hospital-construction-solutions-and-real-world-applications-302672308.html

© 2026 PR Newswire
Tech-Aktien schwanken – 3 Versorger mit Rückenwind
Die Stimmung an den Märkten hat sich grundlegend gedreht. Während Tech- und KI-Werte zunehmend mit Volatilität und Bewertungsrisiken kämpfen, erleben klassische Versorger ein unerwartetes Comeback. Laut IEA und EIA steigt der globale Strombedarf strukturell weiter, nicht nur wegen E-Mobilität und Wärmepumpen, sondern vor allem durch energiehungrige KI-Rechenzentren. Energie wird damit zur zentralen Infrastruktur des digitalen Zeitalters.

Gleichzeitig rücken in unsicheren Marktphasen stabile Cashflows, solide Bilanzen und regulierte Renditen wieder stärker in den Fokus. Genau hier spielen Versorger ihre Stärken aus: berechenbare Erträge, robuste Nachfrage und hohe Dividenden – Qualitäten, die vielen Wachstumswerten aktuell fehlen.

Nach Jahren im Schatten der Tech-Rallye steigt nun das Interesse an Unternehmen, die Stabilität mit langfristigen Wachstumsthemen wie Netzausbau, Dekarbonisierung und erneuerbaren Energien verbinden.

Im aktuellen Spezialreport stellen wir drei Versorger vor, die defensive Stärke mit attraktivem Potenzial kombinieren.

Jetzt den kostenlosen Report sichern – bevor die nächste Versorgerwelle Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.